Anti‐Hepatitis A Virus Antibody Response Elicited in Mice by Different Forms of a Synthetic VP1 Peptide
- 1 July 1995
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 39 (7) , 485-490
- https://doi.org/10.1111/j.1348-0421.1995.tb02232.x
Abstract
Peptide VP1 (11-25) of the capsid of hepatitis A virus was synthesized by the Fmoc-polyamide solid phase method, and administered to mice in different forms: (1) free, (2) encapsulated in multilamellar liposomes, (3) coupled to keyhole limpet hemocyanin (KHL), and (4) incorporated into a tetrameric branched lysine core. The highest anti-VP1 peptide responses were generated by synthetic peptides entrapped into liposomes and coupled to KLH. No anti-HAV response was generated with the free peptide, while all the other forms induced both anti-HAV and HAV-neutralizing antibodies. Maximum neutralization indices were observed in ascites from mice treated with liposome-entrapped and KLH peptides.Keywords
This publication has 26 references indexed in Scilit:
- Use of the colonic carcinoma cell line CaCo‐2 for in vivo amplification and detection of enteric virusesJournal of Medical Virology, 1994
- Prevention of viral hepatitis A: past, present and futureVaccine, 1992
- A rational design of synthetic peptide vaccine with a built‐in adjuvantInternational Journal of Peptide and Protein Research, 1992
- Clinical trial with inactivated hepatitis A vaccine and recommendations for its use.BMJ, 1992
- Synthetic peptides as the basis for vaccine designMolecular Immunology, 1991
- Preparation andin vitroactivity of liposome encapsulated opioidsJournal of Microencapsulation, 1989
- Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virusJournal of Medical Virology, 1987
- Type A Viral HepatitisNew England Journal of Medicine, 1985
- Vaccine AdjuvantsClinical Infectious Diseases, 1980
- Liposomes as immunological adjuvantsNature, 1974